Terms: = Liver cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Staging
5 results:
1. CDX1 Expression Induced by CagA-Expressing
Choi SI; Yoon C; Park MR; Lee D; Kook MC; Lin JX; Kang JH; Ashktorab H; Smoot DT; Yoon SS; Cho SJ
Mol Cancer Res; 2019 Nov; 17(11):2169-2183. PubMed ID: 31416838
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study.
Fatima N; Srivastava AN; Nigam J; Tandon N; Ahmad R; Kumar V
Indian J Pathol Microbiol; 2019; 62(3):384-390. PubMed ID: 31361225
[TBL] [Abstract] [Full Text] [Related]
3. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract] [Full Text] [Related]
4. Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients.
Szavcsur P; Godény M; Bajzik G; Lengyel E; Repa I; Trón L; Boér A; Vincze B; Póti Z; Szabolcs I; Esik O
Eur J Surg Oncol; 2005 Mar; 31(2):183-90. PubMed ID: 15698736
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
[TBL] [Abstract] [Full Text] [Related]
